Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matija Snuderl

Showing results (231-240 of 270) with videos related to

Pageof 27
Sort By:
Neuro-Oncology|January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutantEmilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Neuro-Oncology|December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannomaSimone Schmid, Kanish Mirchia, Anna Tietze, et al.
Nature Communications|November 8, 2023
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinomaIgor Dolgalev, Hua Zhou, Nina Murrell, et al.
Nature Biomedical Engineering|July 10, 2024
Localization of protoporphyrin IX during glioma-resection surgery via paired stimulated Raman histology and fluorescence microscopyMustafa Nasir-Moin, Lisa Irina Wadiura, Vlad Sacalean, et al.
Acta Neuropathologica|July 23, 2017
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcomePooja Panwalkar, Jonathan Clark, Vijay Ramaswamy, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Cancer Discovery|June 24, 2020
Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH InhibitionBryan Ngo, Eugenie Kim, Victoria Osorio-Vasquez, et al.
Pageof 27

Showing results (231-240 of 270) with videos related to

Sort By:
Pageof 27
Neuro-Oncology|January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutantEmilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Neuro-Oncology|December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannomaSimone Schmid, Kanish Mirchia, Anna Tietze, et al.
Nature Communications|November 8, 2023
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinomaIgor Dolgalev, Hua Zhou, Nina Murrell, et al.
Nature Biomedical Engineering|July 10, 2024
Localization of protoporphyrin IX during glioma-resection surgery via paired stimulated Raman histology and fluorescence microscopyMustafa Nasir-Moin, Lisa Irina Wadiura, Vlad Sacalean, et al.
Acta Neuropathologica|July 23, 2017
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcomePooja Panwalkar, Jonathan Clark, Vijay Ramaswamy, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Cancer Discovery|June 24, 2020
Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH InhibitionBryan Ngo, Eugenie Kim, Victoria Osorio-Vasquez, et al.
Pageof 27